WallStreetZenWallStreetZen

NASDAQ: AKYA
Akoya Biosciences Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

AKYA past revenue growth

How has AKYA's revenue growth performed historically?
Company
29.09%
Industry
7.77%
Market
17.2%
AKYA's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
AKYA's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
AKYA's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

AKYA earnings and revenue history

Current Revenue
$96.6M
Current Earnings
-$63.3M
Current Profit Margin
-65.5%

AKYA Return on Equity

Current Company
-110.2%
Current Industry
11.1%
Current Market
188%
AKYA's Return on Equity (-110.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when AKYA announces earnings.

AKYA Return on Assets

Current Company
-36.1%
Current Industry
7.2%
AKYA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

AKYA Return on Capital Employed

Current Company
-37.6%
Current Industry
9.7%
AKYA's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

AKYA vs Medical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
AKYA$96.63M-$45.63M-$63.32M+22.99%N/A
STXS$26.77M-$20.09M-$22.06M-1.82%N/A
INFU$125.79M$16.53M$872.00k+13.38%-13.06%
HBIO$112.25M$8.03M-$3.42M-1.45%N/A
ANGO$324.01M-$169.01M-$192.37M+9.57%N/A
View Top Medical Stocks

AKYA earnings dates

Next earnings date
Jun 4, 2024

Akoya Biosciences Earnings & Revenue FAQ

What were AKYA's earnings last quarter?

On Invalid Date, Akoya Biosciences (NASDAQ: AKYA) reported Q4 2023 earnings per share (EPS) of -$0.20, up 60% year over year. Total Akoya Biosciences earnings for the quarter were -$10.80 million. In the same quarter last year, Akoya Biosciences's earnings per share (EPS) was -$0.50.

If you're new to stock investing, here's how to buy Akoya Biosciences stock.

What was AKYA's earnings growth in the past year?

As of Q2 2024, Akoya Biosciences's earnings has grown year over year. Akoya Biosciences's earnings in the past year totalled -$63.32 million.

What is AKYA's earnings date?

Akoya Biosciences's earnings date is Invalid Date. Add AKYA to your watchlist to be reminded of AKYA's next earnings announcement.

What was AKYA's revenue last quarter?

On Invalid Date, Akoya Biosciences (NASDAQ: AKYA) reported Q4 2023 revenue of $26.49 million up 24.83% year over year. In the same quarter last year, Akoya Biosciences's revenue was $21.22 million.

What was AKYA's revenue growth in the past year?

As of Q2 2024, Akoya Biosciences's revenue has grown 29.09% year over year. This is 21.32 percentage points higher than the US Medical Instruments & Supplies industry revenue growth rate of 7.77%. Akoya Biosciences's revenue in the past year totalled $96.63 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.